Coefficient Bio

Coefficient Bio develops an AI-native platform designed to automate and optimize the pharmaceutical research and development lifecycle. Its technology enables the autonomous drafting of drug development plans and the management of clinical regulatory strategies to identify new drug candidates for medical researchers. The company was founded by former Genentech experts and acquired by Anthropic in 2026.